CareTrust REIT has been upgraded to Zacks Rank #2 (Buy) based on upward trends in earnings estimates. The upgrade reflects improving business fundamentals and positions the stock in the top 20% of Zacks-covered stocks, suggesting potential for near-term price appreciation driven by institutional investor buying pressure.

CareTrust REIT reported strong Q2 2025 financial results, with revenue of $112.469 million and normalized FFO per share of $0.43, exceeding analyst expectations. The company completed its largest acquisition by entering the U.K. market through Care REIT plc, expanding its healthcare property portfolio.

Four companies, including JPMorgan Chase, Williams-Sonoma, Tencent Music Entertainment, and CareTrust REIT, have announced dividend increases of 10% or more, signaling financial strength and a commitment to shareholder returns.

The Ensign Group, Inc. has acquired the operations of nine skilled nursing facilities in Tennessee and Alabama, expanding its presence in the region. The acquisition includes facilities jointly owned by CareTrust REIT, Inc. and Ensign's captive real estate subsidiary, Standard Bearer Healthcare REIT, Inc.

CareTrust REIT reported revenue of $68.89 million, up 33.6% year-over-year, and EPS of $0.36 in Q2 2024. The revenue figure beat the Zacks Consensus Estimate, while EPS was in line with expectations.

During the last three months, 4 analysts shared their evaluations of CareTrust REIT (NYSE:CTRE), revealing diverse outlooks from bullish to bearish. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 1 3 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 0 0 0 2M Ago 0 1 2 0 0 3M Ago 0 0 0 0 0 Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $26.5, a high estimate of $27.00, and a low estimate of $26.00. Observing a 10.42% increase, the current average has risen from the previous average price target of $24.00. Decoding Analyst Ratings: A Detailed Look The analysis of recent analyst actions sheds light on the perception of CareTrust REIT by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Omotayo Okusanya Deutsche Bank Raises Hold $27.00 $23.00 James Feldman Wells Fargo Raises Equal-Weight $26.00 $24.00 Richard Anderson Wedbush Announces Neutral $26.00 - Austin Wurschmidt Keybanc Raises Overweight $27.00 $25.00 Key Insights: Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent ...Full story available on Benzinga.com

Investors need to pay close attention to CareTrust REIT (CTRE) stock based on the movements in the options market lately.

ADNT, CALB and CTRE have been added to the Zacks Rank #5 (Strong Sell) List on June 6, 2024.

Although the revenue and EPS for CareTrust REIT (CTRE) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

CareTrust REIT (CTRE) delivered FFO and revenue surprises of -5.41% and 7.26%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Ryman Hospitality Properties (RHP) delivered FFO and revenue surprises of -8.57% and 0.55%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Red River Bancshares (RRBI) delivered earnings and revenue surprises of 10.48% and 0.50%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?